Ronald Vos's Biography

Home
|
Registration
|
Submissions
- Submission Guidelines
|
Agenda
|
Exhibition
|
Venue
|
Media
|

Ronald Vos, Business Development Manager, SensID

Ronald Vos has been in sales and business development for 30 years now with positions at Thermo, Luminex and Millipore. All these roles where international covering a large area of the world and he worked in Life Science Research as well in Diagnostics. Since 2019 he supports SensID with their business development processes and international marketing.

Accelerate Assay Development and Commercialization Using Reference Materials

Wednesday, 2 March 2022 at 12:00

Add to Calendar ▼2022-03-02 12:00:002022-03-02 13:00:00Europe/LondonAccelerate Assay Development and Commercialization Using Reference MaterialsCirculating Biomarkers, Exosomes and Liquid Biopsy Europe 2022 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

Assay development in clinical genomics is a demanding process especially when complying correctly to all rules and regulations. When assays are becoming even more complex, like in liquid biopsy, where multiplexing becomes the standard and low to ultra low AF frequencies are demanded, the task gets near impossible. Add IVD or FDA demands on top of that and the complexity is that of a giant puzzle with many different aspects. Obtaining the correct and the right amount of clinical samples while facing all these demands is where you can expect friction. For these reasons, there is an acceptance for “contrived” materials but how does it all work. What are the official guidelines?

Add to Calendar ▼2022-03-01 00:00:002022-03-02 00:00:00Europe/LondonCirculating Biomarkers, Exosomes and Liquid Biopsy Europe 2022Circulating Biomarkers, Exosomes and Liquid Biopsy Europe 2022 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors